MedDataX Logo

Ultrasound B Mode Imaging and Elastography

NCT ID: NCT04607187

Last Updated: 2020-10-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-11-30

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Pilot Study on Ultrasound B mode Imaging and Elastography during administration of Xiaflex (collagenase clostridium histolyticum) for Dupuytren's contracture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ultrasound analysis will be obtained on patient that receives Xiaflex as standard of care for Dupuytren's contracture

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dupuytren's Contractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normals, Dupuytren's subjects with and without treatment

Ultrasound analysis of patient receiving treatment for Dupuytren's

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normal Hand or Hand Dupuytren's contracture

Exclusion Criteria

* Previous treatment of Dupuytren's cord
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Endo Pharmaceuticals

INDUSTRY

Sponsor Role collaborator

Theresa Bass-Goldman

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Theresa Bass-Goldman

Principal Investigator Paul J. DeMarco, MD

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Center for Rheumatology and Bone Research a division of Arthritis and Rheumatism Associates, P.C.

Wheaton, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

351-CRBR

Identifier Type: -

Identifier Source: org_study_id